CatalystDerivatives
Cboe Joins Capital Markets Alliance Challenge to CFTC Approval of Single-Stock Perpetual Derivatives
Cboe challenges CFTC approval of single-stock perpetual derivatives via Capital Markets Alliance.
Context
What happened: Cboe Global Markets (Cboe: CBOE) said it joined a Capital Markets Alliance legal action challenging the CFTC's approval of perpetual derivatives on U.S. stocks and ETFs. The CMA includes Cboe, Citadel Securities and Healthy Markets Association.
Key numbers: Cboe launched the world's first listed options exchange in 1973 and cites more than nine decades of securities
Why it matters: Cboe CEO Craig Donohue said the CFTC authorized securities-related product filings that break with decades of precedent, and Cboe is seeking injunctive relief to resolve the uncertainty.
Market: -1.7% today ($343.07), +38.9% YTD, 0.4x vol — as of 17:48 UTC
What changed
Cboe Global Markets (Cboe: CBOE) said it joined a Capital Markets Alliance legal action challenging the CFTC's approval of perpetual derivatives on U.S. stocks and ETFs. The CMA includes Cboe, Citadel Securities and Healthy Markets Association.
Why it matters
Cboe CEO Craig Donohue said the CFTC authorized securities-related product filings that break with decades of precedent, and Cboe is seeking injunctive relief to resolve the uncertainty.
Market: -1.7% today ($343.07), +38.9% YTD, 0.4x vol — as of 17:48 UTC